Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1 1

Status

Unknown 6Recruiting 5Completed 5Not yet recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 219Neoplasms 177Lung Neoplasms 92Prostatic Neoplasms 89Colorectal Neoplasms 88Carcinoma, Non-Small-Cell Lung 48Stomach Neoplasms 45Motor Activity 45Carcinoma, Hepatocellular 45Pancreatic Neoplasms 40Uterine Cervical Neoplasms 39Anxiety Disorders 39Rectal Neoplasms 34Head and Neck Neoplasms 31Colonic Neoplasms 30Pain 26Depression 26Brain Neoplasms 25Polycystic Ovary Syndrome 24Esophageal Neoplasms 24Disease 23Multiple Myeloma 22Hematologic Neoplasms 22Endometrial Neoplasms 22Ovarian Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Urinary Bladder Neoplasms 18Pain, Postoperative 18Glioblastoma 18Liver Neoplasms 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Not yet recruiting × Disease Progression × Clear all
NCT06480721 2024-06-28

FET-POPPING

UMC Utrecht

Phase NA Not yet recruiting
144 enrolled
CNS

Glioblastoma, Disease Progression

NCT05184829 2022-01-11

A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1

Shanghai Zhongshan Hospital

Phase NA Not yet recruiting
500 enrolled

Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡